Download PDF
Semin Neurol 2006; 26(2): 260-270
DOI: 10.1055/s-2006-939926
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Paroxysmal Hemicrania SUNCT, and Hemicrania Continua

Christopher J. Boes1 , Jerry W. Swanson1
  • 1Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota
Further Information

Publication History

Publication Date:
21 April 2006 (online)

    Permissions and Reprints

ABSTRACT

The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders characterized by unilateral pain in the somatic distribution of the trigeminal nerve and ipsilateral autonomic signs, which reflect activation of the cranial parasympathetic pathway. The group includes cluster headache, paroxysmal hemicrania, and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing. Hemicrania continua was previously classified as one of the TACs. Despite their common elements, individually these headaches differ with respect to attack duration, frequency, and response to indomethacin.

KEYWORDS

Chronic paroxysmal hemicrania - episodic paroxysmal hemicrania - short-lasting unilateral neuralgiform headache with conjunctival injection and tearing - hemicrania continua

REFERENCES

  • 1 Goadsby P J, Lipton R B. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.  Brain. 1997;  120 193-209
    CrossrefPubMedGoogle Scholar
  • 2 Headache Classification Subcommittee of the International Headache Society . The international classification of headache disorders, 2nd edition.  Cephalalgia. 2004;  24(suppl 1) 1-160
    PubMedGoogle Scholar
  • 3 Matharu M S, Boes C J, Goadsby P J. Management of trigeminal autonomic cephalgias and hemicrania continua.  Drugs. 2003;  63 1637-1677
    CrossrefPubMedGoogle Scholar
  • 4 Sjaastad O, Dale I. Evidence for a new (?), treatable headache entity.  Headache. 1974;  14 105-108
    CrossrefPubMedGoogle Scholar
  • 5 Sjaastad O, Dale I. A new (?) clinical headache entity “chronic paroxysmal hemicrania.”  Acta Neurol Scand. 1976;  54 140-159
    PubMedGoogle Scholar
  • 6 Kudrow L, Esperanca P, Vijayan N. Episodic paroxysmal hemicrania?.  Cephalalgia. 1987;  7 197-201
    CrossrefPubMedGoogle Scholar
  • 7 Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.  Headache. 1989;  29 648-656
    CrossrefPubMedGoogle Scholar
  • 8 Boes C J, Dodick D W. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients.  Headache. 2002;  42 699-708
    CrossrefPubMedGoogle Scholar
  • 9 Pareja J A. Chronic paroxysmal hemicrania: dissociation of the pain and autonomic features.  Headache. 1995;  35 111-113
    CrossrefPubMedGoogle Scholar
  • 10 Newman L C, Lipton R B. Paroxysmal hemicranias. In: Goadsby PJ, Silberstein SD Headache. Boston; Butterworth-Heinemann 1997: 243-250
    Google Scholar
  • 11 Sjaastad O, Egge K, Horven I et al.. Chronic paroxysmal hemicranial: mechanical precipitation of attacks.  Headache. 1979;  19 31-36
    CrossrefPubMedGoogle Scholar
  • 12 Mulder L JMM, Spierings E LH. Non-lateralized pain in a case of chronic paroxysmal hemicrania?.  Cephalalgia. 2004;  24 52-53
    CrossrefPubMedGoogle Scholar
  • 13 Boes C J, Swanson J W, Dodick D W. Chronic paroxysmal hemicrania presenting as otalgia with a sensation of external acoustic meatus obstruction: two cases and a pathophysiologic hypothesis.  Headache. 1998;  38 787-791
    CrossrefPubMedGoogle Scholar
  • 14 Matharu M S, Goadsby P J. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura.  Neurology. 2001;  56 273-275
    CrossrefPubMedGoogle Scholar
  • 15 Kudrow L. Clinical characteristics. In: Cluster Headache: Mechanisms and Management. Oxford; Oxford University Press 1980: 21-38
    Google Scholar
  • 16 Manzoni G C, Terzano M G, Bono G, Micieli G, Martucci N, Nappi G. Cluster headache: clinical findings in 180 patients.  Cephalalgia. 1983;  3 21-30
    CrossrefPubMedGoogle Scholar
  • 17 Zidverc-Trajkovic J, Pavlovic A M, Mijajlovic M, Jovanovic Z, Sternic N, Kostic V S. Cluster headache and paroxysmal hemicrania: differential diagnosis.  Cephalalgia. 2005;  25 244-248
    CrossrefPubMedGoogle Scholar
  • 18 Boes C. Differentiating paroxysmal hemicrania from cluster headache.  Cephalalgia. 2005;  25 241-243
    CrossrefPubMedGoogle Scholar
  • 19 Pareja J A, Caminero A B, Franco E, Casado J L, Pascual J, Sanchez del Rio M. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua.  Cephalalgia. 2001;  21 906-910
    CrossrefPubMedGoogle Scholar
  • 20 Mathew N T, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania.  Neurology. 2000;  55 316
    PubMedGoogle Scholar
  • 21 Lisotto C, Maggioni F, Mainardi F, Zanchin G. Rofecoxib for the treatment of chronic paroxysmal hemicrania.  Cephalalgia. 2003;  23 318-320
    CrossrefPubMedGoogle Scholar
  • 22 Gobel H, Heinze A, Heinze-Kuhn K. Botulinum toxin A in the treatment of chronic paroxysmal hemicrania: a case report.  Cephalalgia. 2001;  21 506
    PubMedGoogle Scholar
  • 23 Rozen T D. Melatonin as treatment for indomethacin-responsive headaches.  Headache. 2003;  43 591
    PubMedGoogle Scholar
  • 24 Sjaastad O, Saunte C, Salvesen R et al.. Shortlasting, unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea.  Cephalalgia. 1989;  9 147-156
    CrossrefPubMedGoogle Scholar
  • 25 Matharu M S, Cohen A S, Boes C J, Goadsby P J. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.  Curr Pain Headache Rep. 2003;  7 308-318
    PubMedGoogle Scholar
  • 26 Pareja J A, Sjaastad O. SUNCT syndrome: a clinical review.  Headache. 1997;  37 195-202
    CrossrefPubMedGoogle Scholar
  • 27 Pareja J A, Joubert J, Sjaastad O. SUNCT syndrome: atypical temporal patterns.  Headache. 1996;  36 108-110
    CrossrefPubMedGoogle Scholar
  • 28 Pareja J A, Shen J M, Kruszewski P, Caballero V, Pamo M, Sjaastad O. SUNCT syndrome: duration, frequency, and temporal distribution of attacks.  Headache. 1996;  36 161-165
    CrossrefPubMedGoogle Scholar
  • 29 Wingerchuk D M, Nyquist P A, Rodriguez M, Dodick D W. Extratrigeminal short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT): new pathophysiologic entity or variation on a theme?.  Cephalalgia. 2000;  20 127-129
    CrossrefPubMedGoogle Scholar
  • 30 Katusic S, Beard C M, Bergstralh E, Kurland L T. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984.  Ann Neurol. 1990;  27 89-95
    CrossrefPubMedGoogle Scholar
  • 31 Willius F A. Aphorisms of Dr. Charles Horace Mayo and Dr. William James Mayo. Rochester: Mayo Foundation for Medical Education and Research. 1997
    Google Scholar
  • 32 Kinnier Wilson S A. Neuritis. In: Bruce AN Neurology. London; Edward Arnold 1940: 380-392
    Google Scholar
  • 33 Sjaastad O, Kruszewski P. Trigeminal neuralgia and “SUNCT” syndrome-similarities and differences in the clinical pictures: an overview.  Funct Neurol. 1992;  7 103-107
    PubMedGoogle Scholar
  • 34 Harris W. Neuritis and Neuralgia. London; Humphrey Milford, Oxford University Press 1926
    Google Scholar
  • 35 Pareja J A, Barón M, Gili P et al.. Objective assessment of autonomic signs during triggered first division trigeminal neuralgia.  Cephalalgia. 2002;  22 251-255
    CrossrefPubMedGoogle Scholar
  • 36 D'Andrea G, Granella F, Ghiotto N, Nappi G. Lamotrigine in the treatment of SUNCT syndrome.  Neurology. 2001;  57 1723-1725
    PubMedGoogle Scholar
  • 37 Graff-Radford S B. SUNCT syndrome responsive to gabapentin (Neurontin).  Cephalalgia. 2000;  20 515-517
    CrossrefPubMedGoogle Scholar
  • 38 Hunt C H, Dodick D W, Bosch E P. SUNCT responsive to gabapentin.  Headache. 2002;  42 525-526
    CrossrefPubMedGoogle Scholar
  • 39 Matharu M S, Boes C J, Goadsby P J. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate.  Neurology. 2002;  58 1307
    CrossrefPubMedGoogle Scholar
  • 40 Leone M, Franzini A, D'Amico D et al.. Hypothalamic deep brain stimulation to relieve intractable chronic SUNCT: the first case.  Neurology. 2004;  62(suppl 5) A356
    PubMedGoogle Scholar
  • 41 Black D F, Dodick D W. Two cases of medically and surgically intractable SUNCT: a reason for caution and an argument for a central mechanism.  Cephalalgia. 2002;  22 201-204
    CrossrefPubMedGoogle Scholar
  • 42 Medina J L, Diamond S. Cluster headache variant: spectrum of a new headache syndrome.  Arch Neurol. 1981;  38 705-709
    PubMedGoogle Scholar
  • 43 Boghen D, Desaulniers N. Background vascular headache: relief with indomethacin.  Can J Neurol Sci. 1983;  10 270-271
    PubMedGoogle Scholar
  • 44 Sjaastad O, Spierings E L. “Hemicrania continua”: another headache absolutely responsive to indomethacin.  Cephalalgia. 1984;  4 65-70
    CrossrefPubMedGoogle Scholar
  • 45 Dodick D. Hemicrania continua: diagnostic criteria and nosologic status.  Cephalalgia. 2001;  21 869-872
    CrossrefPubMedGoogle Scholar
  • 46 Peres M FP, Silberstein S D, Nahmias S et al.. Hemicrania continua is not that rare.  Neurology. 2001;  57 948-951
    CrossrefPubMedGoogle Scholar
  • 47 Bordini C, Antonaci F, Stovner L J, Schrader H, Sjaastad O. “Hemicrania continua”: a clinical review.  Headache. 1991;  31 20-26
    CrossrefPubMedGoogle Scholar
  • 48 Peres M F, Siow H C, Rozen T D. Hemicrania continua with aura.  Cephalalgia. 2002;  22 246-248
    CrossrefPubMedGoogle Scholar
  • 49 Young W B, Silberstein S D. Hemicrania continua and symptomatic medication overuse.  Headache. 1993;  33 485-487
    CrossrefPubMedGoogle Scholar
  • 50 Lay C L, Newman L C. Post-traumatic hemicrania continua.  Headache. 1999;  39 275-279
    CrossrefPubMedGoogle Scholar
  • 51 Peres M F, Zukerman E. Hemicrania continua responsive to rofecoxib.  Cephalalgia. 2000;  20 130-131
    CrossrefPubMedGoogle Scholar
  • 52 Peres M FP, Silberstein S D. Hemicrania continua responds to cyclooxygenase-2 inhibitors.  Headache. 2002;  42 530-531
    CrossrefPubMedGoogle Scholar
  • 53 Dodick D, Trentman T, Zimmerman R, Eross E. Occipital nerve stimulation for intractable chronic primary headache disorders.  Cephalalgia. 2003;  23 701
    PubMedGoogle Scholar
  • 54 Goadsby P J, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania: evidence for trigemino-parasympathetic activation.  Cephalalgia. 1996;  16 448-450
    CrossrefPubMedGoogle Scholar
  • 55 May A, Bahra A, Buchel C, Frackowiak R SJ, Goadsby P J. PET and MRA findings in cluster headache and MRA in experimental pain.  Neurology. 2000;  55 1328-1335
    PubMedGoogle Scholar
  • 56 May A, Bahra A, Buchel C, Turner R, Goadsby P J. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing.  Ann Neurol. 1999;  46 791-794
    CrossrefPubMedGoogle Scholar
  • 57 Sprenger T, Valet M, Platzer S, Pfaffenrath V, Steude U, Tolle T R. SUNCT: bilateral hypothalamic activation during headache attacks and resolving of symptoms after trigeminal decompression.  Pain. 2005;  113 422-426
    CrossrefPubMedGoogle Scholar
  • 58 Matharu M S, Cohen A S, McGonigle D J, Ward N, Frackowiak R S, Goadsby P J. Posterior hypothalamic and brainstem activation in hemicrania continua.  Headache. 2004;  44 747-761
    CrossrefPubMedGoogle Scholar
  • 59 Dodick D W. Indomethacin-responsive headache syndromes. In: Noseworthy JH Neurological Therapeutics: Principles and Practice. London; Martin Dunitz 2003: 142-150
    Google Scholar
  • 60 Broch A, Horven I, Nornes H, Sjaastad O, Tonjum A. Studies on cerebral and ocular circulation in a patient with cluster headache.  Headache. 1970;  10 1-8
    CrossrefPubMedGoogle Scholar
  • 61 Sjaastad O. Chronic paroxysmal hemicrania. In: Walton J, Warlow CP Major Problems in Neurology: Cluster Headache Syndrome. London; WB Saunders 1992: 291-392
    Google Scholar
  • 62 Hannerz J, Jogestrand T. Intracranial hypertension and sumatriptan efficacy in a case of chronic paroxysmal hemicrania which became bilateral. (The mechanism of indomethacin in CPH.)  Headache. 1993;  33 320-323
    CrossrefPubMedGoogle Scholar
  • 63 Akerman S, Williamson D J, Kaube H, Goadsby P J. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels.  Br J Pharmacol. 2002;  137 62-68
    CrossrefPubMedGoogle Scholar

Christopher J BoesM.D. 

Department of Neurology, Mayo Clinic College of Medicine

200 First Street SW, Rochester, MN 55905

      >